ReviewFrontiers in immunology2023

Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies.

Xinyu Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.